Job Description
Privè Advanced Facial Aesthetics is expanding its medical faculty and invites expressions of interest from NHS Consultant Dermatologists, Plastic Surgeons, and other Consultant-grade doctors with an interest in advanced aesthetic medicine.
Applicants should have completed, or be undertaking, a Level 7 Diploma in Clinical Aesthetic Injectable Treatments with a JCCP-approved provider, or hold equivalent postgraduate aesthetic training and experience.
Clinical Governance and Standards
Privè operates within a robust governance framework and is:
• Save Face accredited (Platinum)
• JCCP approved
• A member of the Cosmetic Redress Scheme
• CQC registration pending
All treatments are delivered within clearly defined clinical protocols, informed consent processes, and evidence-based practice standards.
Centre of Excellence Partnership
In January 2026, Privè entered a formal partnership with The Glow Group, the UK & Eire distributor for Toskani Med / Toskani, an established international pharmaceutical skincare manufacturer, becoming the first UK Toskani Med Centre of Excellence. This partnership provides access to the full professional and homecare Toskani Med and Toskani portfolio.
Regenerative and Injectable Therapies
Privè is the first UK clinic to clinically integrate Lumicen — Synergistic Regeneration with PDRN (3%), a professional regenerative line centred on polydeoxyribonucleotide (PDRN). PDRN has been studied for its role in:
• Cellular repair and tissue regeneration
• Collagen synthesis
• Angiogenesis and dermal hydration
The Lumicen professional range utilises a 3% high-purity PDRN concentration, currently regarded as the highest potency available commercially. The Lumicen Boost Serum has been shortlisted for the 2026 Aesthetics Awards (Innovative Product category).
Energy-Based Transdermal Delivery
Privè offers treatment protocols incorporating the TKN Mesoject Gun, a needle-free mesotherapy system using electroporation (EPM technology). This modality facilitates temporary increases in cell membrane permeability, enabling the transdermal delivery of active compounds without the need for needles, tissue trauma, or patient discomfort.
Biorevitalisation and Skin Boosters
The HA3 / TKN 3 biorevitalisation platform utilises non-crosslinked hyaluronic acid with a molecular weight of 3000 kDa, closely approximating naturally occurring dermal HA. Compared with conventional formulations, the higher molecular weight confers:
• Slower enzymatic degradation
• Enhanced water retention
• Improved tissue turgor and elasticity
Indications include: photoaged skin, dehydration, loss of elasticity, textural irregularities, and adjunctive use alongside dermal fillers.
Objective Clinical Outcomes
Instrument-based assessments using Cutometer analysis have demonstrated:
• Elasticity improvement: 66.1%
• Firmness improvement: 15.3%
• Hydration improvement: 19.8%
Professional Engagement
Privè offers flexible engagement models for Consultant-level clinicians, including sessional, part-time, and independent practice arrangements, with a transparent and competitive profit-share structure.
The clinic operates 7 days per week, with extended hours available for private members. Full administrative, regulatory, and clinical support is provided.
Equity is offered for exceptional candidates.